Sander van der Marel

Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study

Vince Biemans, Andrea E. van der Meulen‐de Jong, C. Janneke van der Woude et al. · Journal of Crohn s and Colitis · 2019 · 184 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Quality of web-based information on inflammatory bowel diseases

Sander van der Marel, Marjolijn Duijvestein, James C.H. Hardwick et al. · Inflammatory Bowel Diseases · 2009 · 125 citations · Full text

Computing, Biomedical Informatics, Health Informatics +16

Mir‐142‐3p target sequences reduce transgene‐directed immunogenicity following intramuscular adeno‐associated virus 1 vector‐mediated gene delivery

Anna Majowicz, Piotr Maczuga, Karin L. Kwikkers et al. · The Journal of Gene Medicine · 2013 · 66 citations

Medicine, Immunology, Molecular Medicine +15

Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study

Tessa Straatmijer, Vince Biemans, Marijn C. Visschedijk et al. · Clinical Gastroenterology and Hepatology · 2022 · 50 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Deficits in Geriatric Assessment Associate With Disease Activity and Burden in Older Patients With Inflammatory Bowel Disease

V Asscher, S Waars, Andrea E. van der Meulen‐de Jong et al. · Clinical Gastroenterology and Hepatology · 2021 · 45 citations · Full text

Medicine, Geriatric Medicine, Geriatric Assessment +14